Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

72 Biggest Movers From Yesterday

ABEO, ACHV, BLUE, BOSC, AVTX, CRI, DHR, DORM, EDIT, EHTH, FATE, FENG

Gainers

  • Spark Therapeutics, Inc. (NASDAQ: ONCE) shares climbed 120.09 percent to close at $113.48 on Monday after Roche Holdings AG (OTC: RHHBY) announced plans to acquire the company for $114.50 per share in cash.
  • Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) gained 74.66 percent to close at $26.06 after the company announced that Ipsen would acquire the company for $25 per share in cash and up to an additional $6 per share depending on FDA acceptance of a new drug application for palovarotene.
  • Planet Green Holdings Corp. (NYSE: PLAG) gained 4.197 percent to close at $4.2875.
  • Uniqure NV (NASDAQ: QURE) shares rose 34.3 percent to close at $55.87. Cantor Fitzgerald maintained uniQure with an Overweight and raised the price target from $68 to $81. Shares of gene therapy companies are trading higher after Roche announced it would acquire Spark Therapeutics for $114.50 per share in cash.
  • Phoenix New Media Limited (NYSE: FENG) climbed 31.94 percent to close at $4.75 after announcing a letter of intent to sell a 32 percent stake in Particle for $448 million in cash. The company also reported a strategic investment in Tadu.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares rose 30.5 percent to close at $1.84 after the company reported a partnership with AllianceRx Walgreens to expand patient access to Probuphine.
  • China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) gained 25.45 percent to close at $6.31.
  • CRISPR Therapeutics AG (NASDAQ: CRSP) shares rose 25.2 percent to close at $39.65. CRISPR Therapeutics posted Q4 loss of $0.92 per share on sales of $115,000. CRISPR Therapeutics and Vertex Pharmaceuticals disclosed that the first patient has been enrolled in a Phase 1/2 clinical study of CTX001 in severe SCD in the U.S. and is expected to be infused with CTX001 in mid-2019.
  • X Financial (NYSE: XYF) gained 23.99 percent to close at $7.08.
  • Libbey Inc. (NYSE: LBY) shares rose 23.88 percent to close at $4.41.
  • AVROBIO, Inc. (NASDAQ: AVRO) surged 21.63 percent to close at $16.98 on Monday.
  • Veritone, Inc. (NASDAQ: VERI) shares jumped 20.45 percent to close at $6.36.
  • Stamps.com Inc. (NASDAQ: STMP) climbed 18.61 percent to close at $99.22 on a buy-the-dip rebound following a 50%+ decline on Friday.
  • SPI Energy Co., Ltd. (NASDAQ: SPI) gained 17.15 percent to close at $2.80.
  • Akcea Therapeutics, Inc. (NASDAQ: AKCA) surged 16.72 percent to close at $31.91 after the company announced Novartis licensed AKCEA-APO(a)-LRx; Akcea is set to receive a $150 million licensing fee that will be split with Ionis equally.
  • Hexindai Inc. (NASDAQ: HX) shares gained 16.42 percent to close at $3.97.
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) rose 16.32 percent to close at $7.20 on Monday after the company received a notice of allowance from the US Patent and Trademark Office for claims directed to its novel voclosporin dosing protocol.
  • Adverum Biotechnologies, Inc. (NASDAQ: ADVM) gained 16.22 percent to close at $4.3000.
  • REGENXBIO Inc. (NASDAQ: RGNX) gained 16.17 percent to close at $54.02.
  • Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) gained 15.28 percent to close at $2.8184.
  • Neurotrope, Inc. (NASDAQ: NTRP) shares rose 14.89 percent to close at $5.17.
  • Uniti Group Inc. (NASDAQ: UNIT) shares surged 14.84 percent to close at $10.60.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 14.66 percent to close at $4.7700.
  • bluebird bio, Inc. (NASDAQ: BLUE) shares gained 14.16 percent to close at $149.91 in sympathy with Roche's acquisition of Spark Therapeutics earlier Monday.
  • Mmtec, Inc. (NASDAQ: MTC) shares gained 13.4 percent to close at $5.50.
  • PPDAI Group Inc. (NYSE: PPDF) rose 13.32 percent to close at $5.02.
  • Abeona Therapeutics Inc. (NASDAQ: ABEO) surged 13.29 percent to close at $7.33.
  • Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) gained 13.14 percent to close at $10.76.
  • Cerecor Inc. (NASDAQ: CERC) climbed 13.06 percent to close at $6.06.
  • Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 12.98 percent to close at $2.35.
  • Fate Therapeutics, Inc. (NASDAQ: FATE) gained 12.83 percent to close at $16.27 on Monday.
  • MeiraGTx Holdings plc (NASDAQ: MGTX) shares jumped 12.54 percent to close at $14.36.
  • Zosano Pharma Corporation (NASDAQ: ZSAN) gained 12.11 percent to close at $5.09.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) surged 12.03 percent to close at $10.52.
  • Nightstar Therapeutics plc (NASDAQ: NITE) rose 11.98 percent to close at $15.89.
  • StoneCo Ltd. (NASDAQ: STNE) shares gained 11.77 percent to close at $29.35 on Monday.
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) climbed 11.63 percent to close at $16.61.
  • Homology Medicines, Inc. (NASDAQ: FIXX) gained 11.47 percent to close at $27.02.
  • Audentes Therapeutics, Inc. (NASDAQ: BOLD) shares rose 11.38 percent to close at $29.26 in sympathy to Roche's acquisition of Spark Therapeutics and an upgrade from Neutral to Buy from Chardan Capital.
  • Anaplan, Inc. (NYSE: PLAN) gained 10.3 percent to close at $36.83 after reporting Q4 results.
  • Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 9.77 percent to close at $17.52.
  • Solid Biosciences Inc. (NASDAQ: SLDB) rose 9.6 percent to close at $9.82.
  • Danaher Corporation (NYSE: DHR) gained 8.52 percent to close at $123.15 after the company announced it would buy General Electric's Life Sciences business for $21.4 billion and that the acquisition would be accretive to adjusted earnings.
  • Summit Wireless Technologies, Inc. (NASDAQ: WISA) shares rose 8.23 percent to close at $2.50.
  • Carter's, Inc. (NYSE: CRI) rose 8.12 percent to close at $100.03 following upbeat Q4 results.
  • Wayfair Inc (NYSE: W) gained 6.89 percent to close at $160.28 after multiple banks reiterated the company's stock with positive ratings following a strong Q4 earnings beat.
  • Westinghouse Air Brake Technologies Corp (NYSE: WAB) gained 6.41 percent to close at $78.06 following Q4 results.
  • General Electric Company (NYSE: GE) shares gained 6.39 percent to close at $10.82 after the company agreed to sell its BioPharma business to Danaher Corporation (NYSE: DHR) for $21.4 billion.
  • Amicus Therapeutics, Inc. (NASDAQ: FOLD) gained 5.87 percent to close at $12.44 after the FDA granted breakthrough therapy designation to the company's AT-GAA.
  • Jianpu Technology Inc. (NYSE: JT) rose 5.83 percent to close at $6.54 after reporting upbeat Q4 results.
  • Voyager Therapeutics, Inc. (NASDAQ: VYGR) rose 5.64 percent to close at $13.86 on Monday after surging 22.85 percent on Friday.
  • Editas Medicine, Inc. (NASDAQ: EDIT) rose 5.33 percent to close at $20.93.

Losers

  • Windstream Holdings, Inc. (NASDAQ: WIN) shares dipped 46.89 percent to close at $0.4530 on rumors of the company declaring bankruptcy.
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares tumbled 19.7 percent to close at $2.65 on Monday after rising 82.32 percent on Friday.
  • Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) shares declined 17.21 percent to close at $0.2401 following late-Friday Dow Jones report that the companywon court permission to draw down remainder of a $155 million bankruptcy financing package.
  • Sunlands Online Education Group (NYSE: STG) shares fell 17.18 percent to close at $4.05.
  • Travelzoo (NASDAQ: TZOO) dipped 14.12 percent to close at $12.71.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares fell 14.06 percent to close at $14.36.
  • Tyme Technologies, Inc. (NASDAQ: TYME) dropped 12.37 percent to close at $2.62.
  • eHealth, Inc. (NASDAQ: EHTH) dropped 11.36 percent to close at $56.25.
  • Ramaco Resources, Inc. (NASDAQ: METC) fell 10.64 percent to close at $5.29 after reporting preliminary 2018 results.
  • Dorman Products Inc. (NASDAQ: DORM) declined 10.42 percent to close at $81.27 after the company issued weak FY19 earnings forecast.
  • Textainer Group Holdings Limited (NYSE: TGH) dipped 10.38 percent to close at $11.40.
  • Research Frontiers Incorporated (NASDAQ: REFR) tumbled 9.83 percent to close at $2.11 on Monday.
  • Overstock.com, Inc. (NASDAQ: OSTK) dropped 9.2 percent to close at $18.06.
  • Riot Blockchain, Inc. (NASDAQ: RIOT) shares declined 9.11 percent to close at $3.59.
  • Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares dropped 9.02 percent to close at $5.95.
  • Blink Charging Co. (NASDAQ: BLNK) shares tumbled 8.83 percent to close at $3.20.
  • Kandi Technologies Group, Inc. (NASDAQ: KNDI) dropped 8.54 percent to close at $8.25.
  • Cronos Group Inc (NASDAQ: CRON) fell 7.62 percent to close at $20.25. Analysts at Jefferies initiated coverage on Cronos with an Underperform rating.
  • B.O.S Better Online Solutions Ltd. (NASDAQ: BOSC) shares fell 5.4 percent to close at $3.33. BOS Better Online Solutions posted Q4 earnings of $0.11 per share on sales of $9.1 million.
  • OncoCyte Corporation (NYSE: OCX) fell 5.19 percent to close at $3.47 after declining 8.50 percent on Friday.